Viral hepatitis is an infection that affects the liver. While there are at least five different types of hepatitis (A-E), the three most common types in the United States are hepatitis A, hepatitis B and hepatitis C.
Hepatitis A is an acute infection and people usually improve without treatment. Hepatitis B and hepatitis C can cause chronic, persistent infections, which can lead to chronic liver disease. There are vaccines to prevent hepatitis A and hepatitis B; however there is no vaccine for hepatitis C.
For information on the hepatitis A outbreak in Michigan please visit: www.mi.gov/hepatitisAoutbreak
- NEW 2018 Viral Hepatitis Annual Surveillance Report
Annual report detailing yearly hepatitis epidemiology and statistics from 2018. Within the report is information on hepatitis B and C infection by age, gender, race, geography, the risk behaviors associated with hepatitis B and C infection, co-infection with HIV, and health outcomes associated with viral hepatitis infection (such as liver cancer and liver transplants). Included in this report are sections on neonatal abstinence syndrome, perinatal hepatitis C, drug poisoning and drug treatment data, and viral hepatitis Medicaid data.
- NEW 2019 Michigan Harm Reduction Summit
The MDHHS Viral Hepatitis Unit hosted its first-ever 2019 Michigan Harm Reduction Summit at the Crowne Plaza Hotel in Lansing on April 2, 2019. Topics included syringe access 101, best practices for syringe services program implementation, harm reduction strategies for reducing the transmission of infectious diseases related to injection drug use, overdose prevention, naloxone distribution, and stigma and cultural competency. Attendees had the opportunity to network and tour two syringe service program mobile units from the Grand Rapids Red Project and Chippewa County Health Department's Safe X-Change Program. A copy of the summit handouts and presentations are available here.
- NEW Q4/Q1 2019 Hepatitis Headlines Newsletter
The latest version of our Hepatitis Headlines Newsletter covers topics such as communicable disease reporting changes, MDSS enhancements, new generic versions of HCV medications, HCV funding for local health departments, new HCV case classification guidance, HCV testing at Michigan Pride Festivals, changes to Michigan Medicaid's Fibrosis Score Restrictions, and new staff updates.
- NEW 2018 Perinatal Hepatitis C Virus Toolkit
Perinatal HCV is becoming a nationally notifiable condition in 2018. As a result, MDHHS developed a toolkit to assist local health departments in case classification, de-duplication and investigation. The toolkit also covers clinical recommendations for HCV testing and treatment of pregnant women and infants born to HCV-infected mothers in addition to sample letters to clinicians and frequently asked questions.
- LHD Hepatitis C Data Quality and Surveillance Reports
In an effort to assist Local Health Departments with HCV surveillance data quality and to help better idenitify possible outbreaks/clusters of HCV infections such that prevention efforts can be opertionalized, the MDHHS Viral Hepatitis Unit will be posting these quarterly reports.
- Viral Hepatitis Stakeholder Forum
Through support from the Association of State and Territorial Health Officials (ASTHO), the MDHHS Viral Hepatitis Unit convened a stakeholder meeting at the MPHI Interactive Learning Center to share the latest Viral Hepatitis Surveillance Report and discuss a diverse set of topics related to viral hepatitis epidemiology, surveillance, and prevention in Michigan. Handouts, presentations, and a recording of the day's meeting can be found here.
- Hepatitis C Screening and Linkage to Care Toolkit
The Hepatitis C Virus Screening and Linkage to Care Toolkit was created to provide resources for HCV screening, testing, reporting and referral to care and treatment.
- Michigan Viral Hepatitis Resource Guide and Directory
Included in this guide is basic information about viral hepatitis and links to important resources throughout the state of Michigan. The guide includes information on local health services, community health centers, health insurance, patient assistance programs, and drug user health. Included is a directory for where patients can go for viral hepatitis vaccinations, testing, and treatment/therapy. If you would like us to update the resource guide please complete this form and e-mail it to us at MDHHS-Hepatitis@michigan.gov.
Look here for information explaining hepatitis, the various methods of transmission, and the best ways to prevent hepatitis infection. Resources are also available on hepatitis related topics, including living with and treating hepatitis.
Information on reporting requirements, prevention efforts, resources, training opportunities and data and statistics related to hepatitis in Michigan.
Summaries of hepatitis activities in Michigan. Included is data on hepatitis A, hepatitis B, perinatal hepatitis B and hepatitis C, along with the Viral Hepatitis Unit quarterly newsletter and annual report.
Information on safe injection practices, including specific information on preventing viral hepatitis infections, how to safely prepare and administer injections, proper care for persons with diabetes, and proper glucose monitoring and insulin injection practices.
Information on the ongoing outbreak of hepatitis A in Michigan, including a summary of the current outbreak, an overview of the disease, methods to protect yourself against infection, educational materials, and other resources.
MDHHS Viral Hepatitis Surveillance and Prevention Unit Contact Information
517-335-8165 (Monday through Friday, 8 A.M. - 5 P.M.)
517-335-9030 (After Hours and Holidays)
Michigan Department of Health and Human Services - Viral Hepatitis Unit
333 South Grand Avenue, 3rd Floor
P.O. Box 30195
Lansing, MI 48933